Protocol for a Phase 3 Trial to Evaluate the Effectiveness and Safety of a Heterologous, Two-Dose Vaccine for Ebola Virus Disease in the Democratic Republic of the Congo
BMJ OPEN(2022)
Key words
public health,Ebola,vaccine,infectious diseases,tropical medicine
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined